Genomic expression patterns of cardiac tissues from dogs with dilated cardiomyopathy

American Journal of Veterinary Research

Volumn 66, Issue 7, 2005, Pages 1140-1155

  Oyama, Mark A ^a   Chittur, Sridar ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GENOMIC DNA; OLIGONUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL ENERGY; CELL STRUCTURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; DOG DISEASE; DOWN REGULATION; ENERGY YIELD; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; RNA HYBRIDIZATION; RNA PROBE; SIGNAL TRANSDUCTION; STRESS; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; CARDIOMYOPATHY, DILATED; DOG DISEASES; DOGS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 23844435646     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.1140     Document Type: Article

References (50)

1. Gilbert SJ, Wotton PR, Bailey AJ, et al. Alterations in the organisation, ultrastructure and biochemistry of the myocardial collagen matrix in doberman pinschers with dilated cardiomyopathy. Res Vet Sci 2000;69:267-274.
2. Meurs KM, Magnon AL, Spier AW et al. Evaluation of the cardiac actin gene in Doberman Pinschers with dilated cardiomyopathy. Am J Vet Res 2001;62:33-36.
3. Spier AW, Meurs KM, Coovert DD, et al. Use of western immunoblot for evaluation of myocardial dystrophin, alpha-sarcoglycan, and beta-dystroglycan in dogs with idiopathic dilated cardiomyopathy. Am J Vet Res 2001;62:67-71.
4. Hwang JJ, Allen PD, Tseng GC, et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 2002;10:31-44.
5. Hwang DM, Dempsey AA, Wang RX, et al. A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation 1997;96:4146-4203.
6. Grzeskowiak R, Witt H, Drungowski M, et al. Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 2003;59:400-411.
7. Steenman M, Chen YW, Le Cunff M, et al. Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 2003;12:97-112.
8. Winer J, Jung CK, Shackel I, et al. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999;270:41-49.
9. Mirotsou M, Watanabe CM, Schultz PG, et al. Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiol Genomics 2003;15:115-126.
10. Cook SA, Rosenzweig A. DNA microarrays: implications for cardiovascular medicine. Circ Res 2002;91:559-564.
11. O'Brien PJ, Duke AL, Shen H, et al. Myocardial mRNA content and stability, and enzyme activities of Ca-cycling and aerobic metabolism in canine dilated cardiomyopathies. Mol Cell Biochem 1995;142:139-150.
12. Tan FL, Moravec CS, Li J, et al. The gene expression fingerprint of human heart failure. Proc Natl Acad Sci U S A 2002;99:11387-11392.
13. Sack MN, Rader TA, Park S, et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996;94:2837-2842.
14. Carvajal K, Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res 2003;34:89-99.
15. McCutcheon LJ, Cory CR, Nowack L, et al. Respiratory chain defect of myocardial mitochondria in idiopathic dilated cardiomyopathy of Doberman pinscher dogs. Can J Physiol Pharmacol 1992;70:1529-1533.
16. Marks AR. Cardiac intracellular calcium release channels: role in heart failure. Circ Res 2000;87:8-11.
17. Cory CR, Shen H, O'Brien PJ. Compensatory asymmetry in down-regulation and inhibition of the myocardial Ca2+ cycle in congestive heart failure produced in dogs by idiopathic dilated cardiomyopathy and rapid ventricular pacing. J Mol Cell Cardiol 1994;26:173-184.
18. Miyamoto MI, del Monte F, Schmidt U, et al. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A 2000;97:793-798.
19. Cohn JN. Abnormalities of peripheral sympathetic nervous system control in congestive heart failure. Circulation 1990;82(suppl 2):159-167.
20. Roth DM, Bayat H, Drumm JD, et al. Adenylyl cyclase increases survival in cardiomyopathy. Circulation 2002;105:1989-1994.
21. Puri PL, Natoli G, Avantaggiati ML, et al. The molecular basis of myocardial hypertrophy. Ann Ital Med Int 1994;9:160-165.
22. Jougasaki M, Wei CM, Heublein DM, et al. Immunohistochemical localization of adrenomedullin in canine heart and aorta. Peptides 1995;16:773-775.
23. Jougasaki M, Grantham JA, Redfield MM, et al. Regulation of cardiac adrenomedullin in heart failure. Peptides 2001;22:1841-1850.
24. Hein S, Kostin S, Heling A, et al. The role of the cytoskeleton in heart failure. Cardiovasc Res 2000;45:273-278.
25. Wu Y, Labeit S, LeWinter MM, et al. Titin: an endosarcomeric protein that modulates myocardial stiffness in DCM. J Card Fail 2002;8:S276-S286.
26. Hein S, Scholz D, Fujitani N, et al. Altered expression of titin and contractile proteins in failing human myocardium. J Mol Cell Cardiol 1994;26:1291-1306.
27. Wu Y, Bell SP, Trombitas K, et al. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation 2002;106:1384-1389.
28. Wu Y, Tobias AH, Bell K, et al. Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy. J Mol Cell Cardiol 2004;37:111-119.
29. McElhinny AS, Kazmierski ST, Labeit S, et al. Nebulin: the nebulous, multifunctional giant of striated muscle. Trends Cardiovasc Med 2003;13:195-201.
30. Selcen D, Krueger BR, Engel AG. Familial cardioneuromyopathy with hyaline masses and nemaline rods: a novel phenotype. Ann Neurol 2002;51:224-234.
31. Lindsey ML, Mann DL, Entman ML, et al. Extracellular matrix remodeling following myocardial injury. Ann Med 2003;35:316-326.
32. Everett RM, McGann J, Wimberly HC, et al. Dilated cardiomyopathy of Doberman pinschers: retrospective histomorphologic evaluation of heart from 32 cases. Vet Pathol 1999;36:221-227.
33. Collins AR, Schnee J, Wang W, et al. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J Am Coll Cardiol 2004;43:1698-1705.
34. Mazzali M, Kipari T, Ophascharoensuk V, et al. Osteopontin - a molecule for all seasons. Q J Med 2002;95:3-13.
35. Denhardt DT, Noda M, O'Regan AW, et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001;107:1055-1061.
36. Sam F, Xie Z, Ooi H, et al. Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. Am J Hypertens 2004;17:188-193.
37. Trueblood NA, Xie Z, Communal C, et al, Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 2001; 88:1080-1087.
38. Schroen DJ, Brinckerhoff CE. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Expr 1996;6:197-207.
39. Gilbert SJ, Wotton PR, Tarlton JF, et al. Increased expression of promatrix metalloproteinase-9 and neutrophil elastase in canine dilated cardiomyopathy. Cardiovasc Res 1997;34:377-383.
40. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002;90:520-530.
41. Thomas CV, Coker ML, Zellner JL, et al. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998;97:1708-1715.
42. Kang YJ. The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol Med 1999;222:263-273.
43. van Dissel JT, Verspaget HW, Feuth HJ, et al. Metallothionein free radical scavenger and cardiovascular morbidity [lett]. Eur Heart J 1997;19:1678.
44. Sukhova GK, Shi GP, Simon DI, et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583.
45. Sharov VG, Sabbah HN, Shimoyama H, et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996;148:141-149.
46. Hewett TE, Grupp IL, Grupp G, et al. Alpha-skeletal actin is associated with increased contractility in the mouse heart. Circ Res 1994;74:740-746.
47. Hurlstone AF, Haramis AP, Wienholds E, et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 2003;425:633-637.
48. Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002;3:195-205.
49. Pikkarainen S, Tokola H, Kerkela R, et al. GATA transcription factors in the developing and adult heart. Cardiovasc Res 2004;63:196-207.
50. Dobson JG Jr, Fray J, Leonard JL, et al. Molecular mechanisms of reduced beta-adrenergic signaling in the aged heart as revealed by genomic profiling. Physiol Genomics 2003;15:142-147.